Twin Capital Management Inc Eli Lilly & CO Transaction History

Twin Capital Management Inc

$853 Million
Q3 2024

A detailed history of Twin Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Twin Capital Management Inc holds 18,051 shares of LLY stock, worth $13.6 Million. This represents 1.88% of its overall portfolio holdings.

Number of Shares

18,051

Previous 17,720 1.87%

Holding current value

$13.6 Million

Previous $16 Million 0.32%

% of portfolio

1.88%

Previous 1.94%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $255,578 - $317,766	331 Added 1.87%	18,051 $16 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $2 Million - $2.51 Million	2,758 Added 18.43%	17,720 $16 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $371,309 - $496,759	627 Added 4.37%	14,962 $11.6 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $2.49 Million - $2.94 Million	-4,749 Reduced 24.88%	14,335 $8.36 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $748,118 - $1.03 Million	1,721 Added 9.91%	19,084 $10.3 Million
Q2 2023 Aug 07, 2023	BUY	$350.74 - $468.98 $823,537 - $1.1 Million	2,348 Added 15.64%	17,363 $8.14 Million
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $1.12 Million - $1.32 Million	-3,612 Reduced 19.39%	15,015 $5.16 Million
Q4 2022 Jan 31, 2023	SELL	$321.55 - $374.67 $94,857 - $110,527	-295 Reduced 1.56%	18,627 $6.82 Million
Q3 2022 Oct 21, 2022	BUY	$296.48 - $337.87 $290,253 - $330,774	979 Added 5.46%	18,922 $6.12 Million
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $224,656 - $263,779	806 Added 4.7%	17,943 $5.82 Million
Q1 2022 May 06, 2022	SELL	$234.69 - $291.66 $98,569 - $122,497	-420 Reduced 2.39%	17,137 $4.91 Million
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $546,835 - $678,625	2,432 Added 16.08%	17,557 $4.85 Million
Q3 2021 Oct 29, 2021	SELL	$221.6 - $272.71 $3.49 Million - $4.3 Million	-15,752 Reduced 51.02%	15,125 $3.5 Million
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $1.57 Million - $2.04 Million	-8,715 Reduced 22.01%	30,877 $7.09 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $1.13 Million - $1.46 Million	-6,860 Reduced 14.77%	39,592 $7.4 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $300,840 - $398,084	-2,306 Reduced 4.73%	46,452 $7.84 Million
Q3 2020 Nov 05, 2020	BUY	$146.22 - $169.13 $228,395 - $264,181	1,562 Added 3.31%	48,758 $7.22 Million
Q2 2020 Aug 04, 2020	SELL	$136.42 - $164.18 $281,570 - $338,867	-2,064 Reduced 4.19%	47,196 $7.75 Million
Q1 2020 Apr 29, 2020	BUY	$119.05 - $147.35 $22,024 - $27,259	185 Added 0.38%	49,260 $6.83 Million
Q4 2019 Jan 29, 2020	SELL	$106.92 - $132.43 $1.73 Million - $2.14 Million	-16,180 Reduced 24.8%	49,075 $6.45 Million
Q3 2019 Oct 28, 2019	SELL	$106.79 - $116.16 $561,181 - $610,420	-5,255 Reduced 7.45%	65,255 $7.3 Million
Q2 2019 Aug 01, 2019	SELL	$110.79 - $129.32 $4.91 Million - $5.73 Million	-44,340 Reduced 38.61%	70,510 $7.81 Million
Q1 2019 May 03, 2019	SELL	$111.31 - $131.02 $1.97 Million - $2.32 Million	-17,716 Reduced 13.36%	114,850 $14.9 Million
Q4 2018 Feb 04, 2019	SELL	$105.9 - $118.64 $140,211 - $157,079	-1,324 Reduced 0.99%	132,566 $15.3 Million
Q3 2018 Nov 08, 2018	BUY	$85.86 - $107.31 $311,671 - $389,535	3,630 Added 2.79%	133,890 $14.4 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $327,781 - $376,190	4,330 Added 3.44%	130,260 $11.1 Million
Q1 2018 May 01, 2018	BUY	$74.21 - $87.6 $2.49 Million - $2.94 Million	33,510 Added 36.26%	125,930 $9.74 Million
Q4 2017 Jan 29, 2018	BUY	$81.94 - $87.89 $171,254 - $183,690	2,090 Added 2.31%	92,420 $7.81 Million
Q3 2017 Nov 09, 2017	BUY	$77.07 - $85.54 $3.17 Million - $3.52 Million	41,150 Added 83.67%	90,330 $7.73 Million
Q2 2017 Aug 07, 2017	BUY	N/A	49,180	49,180 $4.05 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Twin Capital Management Inc with notifications on news.

Account

Twin Capital Management Inc Eli Lilly & CO Transaction History